cefdinir brands

6 registered brands containing cefdinir in Kenya.

Molecular formula: C14H13N5O5S2

Five-member thiazolidine rings that make up penicillins are replaced in cephalosporins by a six-member dihydrothiazine ring, conferring greater bactericidal activity. This 6-member ring enables cefdinir and other cephalosporins to resist inactivation by certain bacterial enzymes. With a mechanism similar to other beta-lactam antibiotics, the bactericidal activity of cefdinir is caused by the inhibition of cell wall synthesis via binding to penicillin-binding proteins (PBPs). Cefdinir, like other cephalosporins, penetrates the bacterial cell wall, combats inactivation by beta-lactamase enzymes, and inactivates penicillin-binding proteins. This interferes with the final step of transpeptidation in cell walls, eventually leading to cell lysis, which eventually leads to the death of bacteria that are susceptible to this drug. Cefdinir has shown affinity to penicillin protein binding proteins 2 and 3. It has also been shown to inhibit transpeptidase enzymes of various bacteria, which may play a role in its bactericidal action. One in vitro study suggests that cefdinir inhibits myeloperoxidase release extracellularly. The impact of this potential drug target in relation to its mechanism of action is unknown.

Source: PubChem (NCBI) ยท compound 6915944

Product Manufacturer Status Country
AKUDINIR 125MG ORAL SUSPENSION
125MG
Unisel Registered Kenya
AKUDINIR 250MG SUSPENSION
250MG
Unisel Registered Kenya
AKUDINIR 300
300MG
Unisel Registered Kenya
ALDINIR FOR ORAL SUSPENSION
EACH 5 ML (ONE TEASPOONFUL) OF RECONSTITUTED SUSPENSION CONTAINS: CEFDINIR 125 MG EXCIPIENTS Q.S.
Europa Healthcare Registered Kenya
LABNIR CAPSULES
EACH CAPSULE CONTAINS CEFDINIR USP 300MG
Laboratory & Allied Registered Kenya
LABNIR FOR ORAL SUSPENSION
EACH 5ML OF THE RECONSTITUTED SUSPENSION CONTAINS: CEFDINIR USP 125MG
Laboratory & Allied Registered Kenya